The appropriate choice depends on individual health goals, risk factors, contraindications, and preferences regarding the balance between potential benefits and side effect profiles
Relational adaptation may also require attention
But when calorie intake drops significantly especially without nutritional planning fatigue can follow
However, anyone with a personal or family history of medullary thyroid cancer, MEN2 syndrome, severe pancreatitis, or severe gastroparesis should not use semaglutide
"Just like any other chronic disease, such as high blood pressure or high cholesterol, obesity should be treated as such." Why obesity has become more common Semaglutide is part of a class of drugs called GLP-1 agonists, which mimic a hormone that signals to the brain when a person is full
The Short-Term Efficacy Conundrum GLP-1 agonists have garnered attention for their ability to induce rapid weight loss and improve glucose control